tag:blogger.com,1999:blog-4241416962008169508.post6915233420199207250..comments2024-03-27T21:03:58.972-04:00Comments on Just A Life Sciences Blog...: A Commenter's Largely-Rhetorical Questions -- and My Non-Rhetorical RepliesUnknownnoreply@blogger.comBlogger4125tag:blogger.com,1999:blog-4241416962008169508.post-37570750269372369922010-08-17T15:49:12.999-04:002010-08-17T15:49:12.999-04:00Web design
very handy, thanx a lot for this blgo ....<a href="http://blitzcrest.com/" rel="nofollow">Web design</a><br />very handy, thanx a lot for this blgo ..... Ths is what I wass looking for.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-4241416962008169508.post-87188737836320285122008-05-04T12:54:00.000-04:002008-05-04T12:54:00.000-04:00It's a pleasure, to be sure. The quality of your ...It's a pleasure, to be sure. The quality of your analysis is interesting and thorough and for that I thank you. The presence of actual documents lend credibility and short bursts of humor/personality make it readable. In addition, the absence of gross, unacceptable language and inappropriate metaphors elevates this forum above others where course language is tolerated.<BR/><BR/>It all began with Zetia and the jumprope - the title of a new novel perhaps?<BR/><BR/>Until next time...AdieuAnonymousnoreply@blogger.comtag:blogger.com,1999:blog-4241416962008169508.post-91178115346067174022008-05-04T01:04:00.000-04:002008-05-04T01:04:00.000-04:00Thank you. Truly well-put.I think, in a future po...Thank you. Truly well-put.<BR/><BR/>I think, in a future post, I will take a much closer tour through what one pharma's (Schering's) real, risk-adjusted, cost structure actually looks like -- for I do think we are often misled into think that it is higher than it is. Said another way, I think the profit margin on many flagship pharma products is actually understated. we shall see.<BR/><BR/>Please do return, Anon.<BR/><BR/>The dialogue may only continue -- if more than one voice is speaking.<BR/><BR/>Otherwise -- mine is simply a monologue -- and that is ultimately rather boring (to all, not just me!). Heh. <BR/><BR/>Thank you.Anonymousnoreply@blogger.comtag:blogger.com,1999:blog-4241416962008169508.post-51478982949604745102008-05-04T00:40:00.000-04:002008-05-04T00:40:00.000-04:00Well done. The commenter's "largely-rhetorical que...Well done. <BR/><BR/>The commenter's "largely-rhetorical questions" produced the discussion that needed to be had. The questions were intentional and seem to have been productive. <BR/><BR/>No one "demanded" the responsibility to be taken on to be sure, the point is made to remind consumers of pharmaceuticals that these companies add much to our health and these benefits should be measured by means in addition to cost. <BR/><BR/>It is not the commenter that proposes an "either/or" philosophy. Many "expect" pricing to be at some level that is often unreasonably low given the investment and risk without taking the health benefits into consideration. The discussion of "Big Pharma" is most commonly based solely on price. The moniker alone creates a suggestion that they can easily afford to subsidize. <BR/><BR/>There must be fair, not unbalanced reimbursement for the value received. (Hint: Perhaps a review of the insurance industry or pharmacy acquisition prices vs sales price is in order.) Retail pricing is always blamed on pharma when in fact, pharmacies are responsible as well. (Ask why pharmacies can suddenly offer a laundry list of drugs for $4.00...)<BR/><BR/>Perhaps there are several issues around compensation that could be explored. Certainly top execs deserve reward - we are capitalists after all. Especially constructive is the discussion of the pay package (of all executives) which is top heavy and exorbitant based on the results you cite. In addition, the philosophy of rewarding those that create success does not seem to extend to many past the top line, hence the suggestion that perhaps the top should be somehow connected to the middle and bottom layers of the company. A smart company would include, not exclude players that help make a success, would it not? <BR/><BR/>Between us there are multiple points of dialogue - The initial Enhance discussion and the behavior of the executives. Assuredly they are intertwined. <BR/><BR/>We leave the Enhance discussion to play out and IMPROVIT to lend the science of which you speak. The executives need your scrutiny. It is agreed that the pay structure is swollen and without accountability. Your musings on non-performance sees through the veil placed to disguise and distract. Yes, let's poke those sleepy bears and look forward to May 8.<BR/><BR/>Schering produces and sells quality products because of many fine employees. Actions of the executives that cause precipitous drops in value of the company, morale or pension fund should be held accountable and not just sent to golden parachute heaven.<BR/><BR/>Let's hope Mr. Hassan pays some attention.Anonymousnoreply@blogger.com